Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant.
Saved in:
| Title: | Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant. |
|---|---|
| Authors: | Aurelia LC; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Purcell RA; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Theisen RM; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States., Kelly A; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Esterbauer R; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Ramanathan P; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Lee WS; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Wines BD; Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia.; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia., Hogarth PM; Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia.; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia., Juno JA; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Allen LF; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Bond KA; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Victorian Infectious Disease Reference Laboratory (VIDRL), at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Department of Microbiology, Royal Melbourne Hospital, Melbourne, VIC, Australia., Williamson DA; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; School of Medicine, University of St Andrews, Fife KY16 9TF, Scotland., Trevillyan JM; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, VIC, Australia., Trubiano JA; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, VIC, Australia.; Centre for Antibiotic Allergy and Research, National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Nguyen TH; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Kedzierska K; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Wheatley AK; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Melbourne, VIC, Australia., Arnold KB; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States., Selva KJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Chung AW; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia. |
| Source: | Science advances [Sci Adv] 2025 Feb 28; Vol. 11 (9), pp. eads1482. Date of Electronic Publication: 2025 Feb 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40009690 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Aurelia+LC%22">Aurelia LC</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Purcell+RA%22">Purcell RA</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Theisen+RM%22">Theisen RM</searchLink>; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Kelly+A%22">Kelly A</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Esterbauer+R%22">Esterbauer R</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Ramanathan+P%22">Ramanathan P</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+WS%22">Lee WS</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Wines+BD%22">Wines BD</searchLink>; Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia.; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Hogarth+PM%22">Hogarth PM</searchLink>; Immune Therapies Group, Burnet Institute, Melbourne, VIC, Australia.; Department of Clinical Pathology, University of Melbourne, Melbourne, VIC, Australia.; Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Juno+JA%22">Juno JA</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Allen+LF%22">Allen LF</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Bond+KA%22">Bond KA</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Victorian Infectious Disease Reference Laboratory (VIDRL), at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.; Department of Microbiology, Royal Melbourne Hospital, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Williamson+DA%22">Williamson DA</searchLink>; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; School of Medicine, University of St Andrews, Fife KY16 9TF, Scotland.<br /><searchLink fieldCode="AU" term="%22Trevillyan+JM%22">Trevillyan JM</searchLink>; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Trubiano+JA%22">Trubiano JA</searchLink>; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, VIC, Australia.; Centre for Antibiotic Allergy and Research, National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Nguyen+TH%22">Nguyen TH</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kedzierska+K%22">Kedzierska K</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Wheatley+AK%22">Wheatley AK</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kent+SJ%22">Kent SJ</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Arnold+KB%22">Arnold KB</searchLink>; Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Selva+KJ%22">Selva KJ</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chung+AW%22">Chung AW</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101653440%22">Science advances</searchLink> [Sci Adv] 2025 Feb 28; Vol. 11 (9), pp. eads1482. <i>Date of Electronic Publication: </i>2025 Feb 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+the+Advancement+of+Science%22">American Association for the Advancement of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101653440 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2375-2548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223752548%22">23752548 </searchLink><i>NLM ISO Abbreviation: </i>Sci Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40009690 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1126/sciadv.ads1482 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: eads1482 Titles: – TitleFull: Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aurelia LC – PersonEntity: Name: NameFull: Purcell RA – PersonEntity: Name: NameFull: Theisen RM – PersonEntity: Name: NameFull: Kelly A – PersonEntity: Name: NameFull: Esterbauer R – PersonEntity: Name: NameFull: Ramanathan P – PersonEntity: Name: NameFull: Lee WS – PersonEntity: Name: NameFull: Wines BD – PersonEntity: Name: NameFull: Hogarth PM – PersonEntity: Name: NameFull: Juno JA – PersonEntity: Name: NameFull: Allen LF – PersonEntity: Name: NameFull: Bond KA – PersonEntity: Name: NameFull: Williamson DA – PersonEntity: Name: NameFull: Trevillyan JM – PersonEntity: Name: NameFull: Trubiano JA – PersonEntity: Name: NameFull: Nguyen TH – PersonEntity: Name: NameFull: Kedzierska K – PersonEntity: Name: NameFull: Wheatley AK – PersonEntity: Name: NameFull: Kent SJ – PersonEntity: Name: NameFull: Arnold KB – PersonEntity: Name: NameFull: Selva KJ – PersonEntity: Name: NameFull: Chung AW IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 02 Text: 2025 Feb 28 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2375-2548 Numbering: – Type: volume Value: 11 – Type: issue Value: 9 Titles: – TitleFull: Science advances Type: main |
| ResultId | 1 |